Bong Koh Net Worth & Insider Trades
Bong Koh Unum Therapeutics Inc
What is Bong Koh's Net Worth?
The current estimated net worth of Unum Therapeutics Inc's Bong Koh is estimated to be about $727.72M . Bong Koh owns about 4,355,273 units of Unum Therapeutics Inc common stock. Recently at Unum Therapeutics Inc, Bong Koh has sold an estimated value of $0 worth.
What is Bong Koh's Past Insider Trading?
Bong Koh's largest purchase order was 451,000 units , worth over $1.14M on August 18, 2020. In total, Bong Koh has made about 1 transaction recently at Unum Therapeutics Inc. Bong Koh usually trades in August, with the busiest year in 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Venrock Healthcare Capital Partners III LP, Venrock Healthcare Capital Partners II LP, VHCP CoInvestment Holdings II LLC, VHCP CoInvestment Holdings III LLC, VHCP Management II LLC, VHCP Management III LLC, Bong Koh, Nimish Shah
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Bong Koh's' Mailing Address?
- Mailing address is 7 Bryant Park 23rd Floor New York NY 10018 NY
What are Unum Therapeutics Inc's Past Insider Trades?
Unum Therapeutics Inc's most recent insider trade came on August 18, 2020 by Venrock Healthcare Capital Partners Iii Lp, Venrock Healthcare Capital Partners Ii Lp, Vhcp Coinvestment Holdings Ii Llc, Vhcp Coinvestment Holdings Iii Llc, Vhcp Management Ii Llc, Vhcp Management Iii Llc, Bong Koh and Nimish Shah who bought 451,000 units worth $1.14M . In the last 2 years, insiders at Unum Therapeutics Inc have sold an estimated value of $533.62K and bought an estimated value of $11.14M worth of shares. Insider trading is most common in April, with the busiest year in 2019. The most active traders at the company are Bruce Booth, Director, Jean Karen Ferrante, Director, and Jorn Aldag, Director .
Unum Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |